Icad Historical Financial Ratios

ICAD Stock  USD 1.56  0.08  4.88%   
Icad is lately reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.29 or Days Sales Outstanding of 105 will help investors to properly organize and evaluate icad inc financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

About Icad Financial Ratios Analysis

icad incFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Icad investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Icad financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Icad history.

Icad Financial Ratios Chart

At present, Icad's Days Of Inventory On Hand is projected to increase significantly based on the last few years of reporting. The current year's Capex To Operating Cash Flow is expected to grow to 0.27, whereas Days Sales Outstanding is forecasted to decline to 104.68.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing icad inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Icad sales, a figure that is much harder to manipulate than other icad inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.
Most ratios from Icad's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into icad inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
At present, Icad's Days Of Inventory On Hand is projected to increase significantly based on the last few years of reporting. The current year's Capex To Operating Cash Flow is expected to grow to 0.27, whereas Days Sales Outstanding is forecasted to decline to 104.68.
 2021 2022 2023 2024 (projected)
Payables Turnover3.384.123.913.08
Days Of Inventory On Hand162.05241.88120.31202.68

Icad fundamentals Correlations

-0.50.88-0.770.6-0.250.92-0.80.05-0.50.990.930.94-0.11-0.790.0-0.370.140.0-0.320.120.22-0.030.070.38-0.4
-0.5-0.440.27-0.090.86-0.660.640.041.0-0.48-0.66-0.63-0.040.640.0-0.040.00.240.26-0.320.14-0.04-0.330.040.37
0.88-0.44-0.860.44-0.190.85-0.8-0.19-0.440.860.850.87-0.21-0.650.12-0.330.06-0.17-0.40.2-0.1-0.040.110.32-0.26
-0.770.27-0.86-0.37-0.03-0.760.710.040.27-0.77-0.76-0.760.340.64-0.180.23-0.08-0.020.690.020.0-0.20.19-0.24-0.05
0.6-0.090.44-0.37-0.010.56-0.350.17-0.090.610.550.550.22-0.25-0.330.090.190.010.26-0.110.520.040.03-0.05-0.54
-0.250.86-0.19-0.03-0.01-0.310.360.20.86-0.19-0.3-0.280.060.26-0.15-0.080.120.330.0-0.160.29-0.09-0.20.020.21
0.92-0.660.85-0.760.56-0.31-0.840.13-0.660.931.00.990.0-0.88-0.09-0.140.21-0.02-0.380.260.2-0.030.240.11-0.52
-0.80.64-0.80.71-0.350.36-0.840.340.64-0.73-0.84-0.840.170.7-0.150.340.340.450.46-0.270.23-0.11-0.2-0.410.29
0.050.04-0.190.040.170.20.130.340.040.190.130.110.38-0.3-0.440.420.810.910.0-0.070.85-0.210.01-0.54-0.31
-0.51.0-0.440.27-0.090.86-0.660.640.04-0.48-0.66-0.63-0.040.640.0-0.040.00.240.26-0.320.14-0.04-0.330.040.37
0.99-0.480.86-0.770.61-0.190.93-0.730.19-0.480.940.94-0.05-0.83-0.09-0.30.30.13-0.330.10.33-0.050.060.27-0.43
0.93-0.660.85-0.760.55-0.31.0-0.840.13-0.660.940.990.0-0.88-0.09-0.140.21-0.01-0.380.250.2-0.030.240.11-0.52
0.94-0.630.87-0.760.55-0.280.99-0.840.11-0.630.940.99-0.02-0.84-0.06-0.240.2-0.02-0.350.250.18-0.060.220.19-0.49
-0.11-0.04-0.210.340.220.060.00.170.38-0.04-0.050.0-0.02-0.02-0.910.440.250.130.350.020.49-0.190.26-0.51-0.56
-0.790.64-0.650.64-0.250.26-0.880.7-0.30.64-0.83-0.88-0.84-0.020.160.1-0.31-0.170.56-0.18-0.28-0.06-0.12-0.060.38
0.00.00.12-0.18-0.33-0.15-0.09-0.15-0.440.0-0.09-0.09-0.06-0.910.16-0.41-0.39-0.21-0.210.05-0.640.09-0.120.480.47
-0.37-0.04-0.330.230.09-0.08-0.140.340.42-0.04-0.3-0.14-0.240.440.1-0.410.290.230.11-0.030.260.110.12-0.94-0.23
0.140.00.06-0.080.190.120.210.340.810.00.30.210.20.25-0.31-0.390.290.80.04-0.050.69-0.230.0-0.5-0.26
0.00.24-0.17-0.020.010.33-0.020.450.910.240.13-0.01-0.020.13-0.17-0.210.230.8-0.06-0.130.74-0.26-0.14-0.34-0.04
-0.320.26-0.40.690.260.0-0.380.460.00.26-0.33-0.38-0.350.350.56-0.210.110.04-0.060.090.2-0.360.32-0.11-0.4
0.12-0.320.20.02-0.11-0.160.26-0.27-0.07-0.320.10.250.250.02-0.180.05-0.03-0.05-0.130.09-0.17-0.790.94-0.01-0.51
0.220.14-0.10.00.520.290.20.230.850.140.330.20.180.49-0.28-0.640.260.690.740.2-0.17-0.16-0.06-0.33-0.4
-0.03-0.04-0.04-0.20.04-0.09-0.03-0.11-0.21-0.04-0.05-0.03-0.06-0.19-0.060.090.11-0.23-0.26-0.36-0.79-0.16-0.78-0.010.51
0.07-0.330.110.190.03-0.20.24-0.20.01-0.330.060.240.220.26-0.12-0.120.120.0-0.140.320.94-0.06-0.78-0.16-0.72
0.380.040.32-0.24-0.050.020.11-0.41-0.540.040.270.110.19-0.51-0.060.48-0.94-0.5-0.34-0.11-0.01-0.33-0.01-0.160.26
-0.40.37-0.26-0.05-0.540.21-0.520.29-0.310.37-0.43-0.52-0.49-0.560.380.47-0.23-0.26-0.04-0.4-0.51-0.40.51-0.720.26
Click cells to compare fundamentals

Icad Account Relationship Matchups

Icad fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio4.569.845.31.652.625.08
Ptb Ratio28.169.573.841.321.361.29
Days Sales Outstanding114.36123.2496.47116.22134.72104.68
Book Value Per Share0.410.281.381.881.31.24
Free Cash Flow Yield(0.0678)(0.0519)(0.0255)(0.056)(0.29)(0.13)
Invested Capital4.440.290.02480.0970.01380.0131
Pb Ratio28.169.573.841.321.361.29
Ev To Sales4.799.224.321.011.391.32
Free Cash Flow Per Share(0.25)(0.4)(0.34)(0.53)(0.24)(0.26)
Roic(0.7)(0.41)(0.23)(0.24)(0.36)(0.22)
Inventory Turnover2.722.652.251.513.032.28
Net Income Per Share(0.54)(0.74)(0.8)(0.45)(0.29)(0.3)
Days Of Inventory On Hand133.98137.53162.05241.88120.31202.68
Payables Turnover3.572.913.384.123.913.08
Sales General And Administrative To Revenue0.360.240.310.40.540.53
Capex To Revenue(0.009764)(0.016)(0.0175)(0.0191)(0.073)(0.0693)
Cash Per Share0.730.831.231.380.850.74
Pocfratio(20.09)(41.84)(18.96)(3.61)(9.13)(8.68)
Interest Coverage(8.16)(19.72)(76.11)(480.56)(552.65)(525.01)
Capex To Operating Cash Flow0.04310.06790.06240.04180.250.27
Pfcf Ratio(19.26)(39.18)(17.85)(3.46)(7.28)(7.64)
Days Payables Outstanding102.12125.5107.9788.5693.41134.7
Income Quality0.520.40.840.940.710.74
Roe(2.67)(0.58)(0.24)(0.39)(0.22)(0.23)
Ev To Operating Cash Flow(21.1)(39.2)(15.44)(2.2)(4.86)(4.62)
Pe Ratio(10.54)(16.6)(15.86)(3.38)(6.09)(6.4)
Return On Tangible Assets(0.41)(0.42)(0.38)(0.21)(0.23)(0.24)
Ev To Free Cash Flow(20.23)(36.71)(14.53)(2.12)(3.87)(4.07)
Earnings Yield(0.0949)(0.0603)(0.063)(0.3)(0.16)(0.17)
Intangibles To Total Assets0.310.230.170.150.210.2
Net Debt To E B I T D A(0.6)1.143.261.352.913.06
Tangible Book Value Per Share(0.24)0.961.511.030.971.65
Receivables Turnover3.192.963.783.142.713.49

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Icad Stock

When determining whether icad inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in icad inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.20)
Revenue Per Share
0.693
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.08)
Return On Equity
(0.16)
The market value of icad inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.